Indole as a new tentative marker in exhaled breath for non-invasive blood glucose monitoring of diabetic subjects
Blood glucose monitoring (BGM) is the most important part of diabetes management. In classical BGM, glucose measurement by test strips involves invasive finger pricking. We present results of a clinical study that focused on a non-invasive approach based on volatile organic compounds (VOCs) in exhal...
Saved in:
Published in | Journal of breath research Vol. 16; no. 2; pp. 026001 - 26019 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
IOP Publishing
01.04.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Blood glucose monitoring (BGM) is the most important part of diabetes management. In classical BGM, glucose measurement by test strips involves invasive finger pricking. We present results of a clinical study that focused on a non-invasive approach based on volatile organic compounds (VOCs) in exhaled breath. Main objective was the discovery of markers for prediction of blood glucose levels (BGL) in diabetic patients. Exhaled breath was measured repeatedly in 60 diabetic patients (30 type 1, 30 type 2) in fasting state and after a standardized meal. Proton Transfer Reaction Time of Flight Mass Spectrometry (PTR-ToF-MS) was used to sample breath every 15 minutes for a total of six hours. BGLs were tested in parallel via BGM test strips. VOC signals were plotted against glucose trends for each subject to identify correlations. Exhaled indole (a bacterial metabolite of tryptophan) showed significant mean correlation to BGL (with negative trend) and significant individual correlation in 36 patients. The type of diabetes did not affect this result. Additional experiments of one healthy male subject by ingestion of lactulose and 13C-labeled glucose (n=3) revealed that exhaled indole does not directly originate from food digestion by intestinal microbiota. As indole has been linked to human glucose metabolism, it might be a tentative marker in breath for non-invasive BGM. Clinical studies with greater diversity are required for confirmation of such results and further investigation of metabolic pathways. |
---|---|
AbstractList | Blood glucose monitoring (BGM) is the most important part of diabetes management. In classical BGM, glucose measurement by test strips involves invasive finger pricking. We present results of a clinical study that focused on a non-invasive approach based on volatile organic compounds (VOCs) in exhaled breath. Main objective was the discovery of markers for prediction of blood glucose levels (BGLs) in diabetic patients. Exhaled breath was measured repeatedly in 60 diabetic patients (30 type 1, 30 type 2) in fasting state and after a standardized meal. Proton transfer reaction time of flight mass spectrometry was used to sample breath every 15 min for a total of 6 h. BGLs were tested in parallel via BGM test strips. VOC signals were plotted against glucose trends for each subject to identify correlations. Exhaled indole (a bacterial metabolite of tryptophan) showed significant mean correlation to BGL (with negative trend) and significant individual correlation in 36 patients. The type of diabetes did not affect this result. Additional experiments of one healthy male subject by ingestion of lactulose and
C-labeled glucose (
= 3) revealed that exhaled indole does not directly originate from food digestion by intestinal microbiota. As indole has been linked to human glucose metabolism, it might be a tentative marker in breath for non-invasive BGM. Clinical studies with greater diversity are required for confirmation of such results and further investigation of metabolic pathways. Blood glucose monitoring (BGM) is the most important part of diabetes management. In classical BGM, glucose measurement by test strips involves invasive finger pricking. We present results of a clinical study that focused on a non-invasive approach based on volatile organic compounds (VOCs) in exhaled breath. Main objective was the discovery of markers for prediction of blood glucose levels (BGL) in diabetic patients. Exhaled breath was measured repeatedly in 60 diabetic patients (30 type 1, 30 type 2) in fasting state and after a standardized meal. Proton Transfer Reaction Time of Flight Mass Spectrometry (PTR-ToF-MS) was used to sample breath every 15 minutes for a total of six hours. BGLs were tested in parallel via BGM test strips. VOC signals were plotted against glucose trends for each subject to identify correlations. Exhaled indole (a bacterial metabolite of tryptophan) showed significant mean correlation to BGL (with negative trend) and significant individual correlation in 36 patients. The type of diabetes did not affect this result. Additional experiments of one healthy male subject by ingestion of lactulose and 13C-labeled glucose (n=3) revealed that exhaled indole does not directly originate from food digestion by intestinal microbiota. As indole has been linked to human glucose metabolism, it might be a tentative marker in breath for non-invasive BGM. Clinical studies with greater diversity are required for confirmation of such results and further investigation of metabolic pathways. Blood glucose monitoring (BGM) is the most important part of diabetes management. In classical BGM, glucose measurement by test strips involves invasive finger pricking. We present results of a clinical study that focused on a non-invasive approach based on volatile organic compounds (VOCs) in exhaled breath. Main objective was the discovery of markers for prediction of blood glucose levels (BGLs) in diabetic patients. Exhaled breath was measured repeatedly in 60 diabetic patients (30 type 1, 30 type 2) in fasting state and after a standardized meal. Proton transfer reaction time of flight mass spectrometry was used to sample breath every 15 min for a total of 6 h. BGLs were tested in parallel via BGM test strips. VOC signals were plotted against glucose trends for each subject to identify correlations. Exhaled indole (a bacterial metabolite of tryptophan) showed significant mean correlation to BGL (with negative trend) and significant individual correlation in 36 patients. The type of diabetes did not affect this result. Additional experiments of one healthy male subject by ingestion of lactulose and 13C-labeled glucose (n = 3) revealed that exhaled indole does not directly originate from food digestion by intestinal microbiota. As indole has been linked to human glucose metabolism, it might be a tentative marker in breath for non-invasive BGM. Clinical studies with greater diversity are required for confirmation of such results and further investigation of metabolic pathways. Blood glucose monitoring (BGM) is the most important part of diabetes management. In classical BGM, glucose measurement by test strips involves invasive finger pricking. We present results of a clinical study that focused on a non-invasive approach based on volatile organic compounds (VOCs) in exhaled breath. Main objective was the discovery of markers for prediction of blood glucose levels (BGLs) in diabetic patients. Exhaled breath was measured repeatedly in 60 diabetic patients (30 type 1, 30 type 2) in fasting state and after a standardized meal. Proton transfer reaction time of flight mass spectrometry was used to sample breath every 15 min for a total of 6 h. BGLs were tested in parallel via BGM test strips. VOC signals were plotted against glucose trends for each subject to identify correlations. Exhaled indole (a bacterial metabolite of tryptophan) showed significant mean correlation to BGL (with negative trend) and significant individual correlation in 36 patients. The type of diabetes did not affect this result. Additional experiments of one healthy male subject by ingestion of lactulose and13C-labeled glucose (n= 3) revealed that exhaled indole does not directly originate from food digestion by intestinal microbiota. As indole has been linked to human glucose metabolism, it might be a tentative marker in breath for non-invasive BGM. Clinical studies with greater diversity are required for confirmation of such results and further investigation of metabolic pathways.Blood glucose monitoring (BGM) is the most important part of diabetes management. In classical BGM, glucose measurement by test strips involves invasive finger pricking. We present results of a clinical study that focused on a non-invasive approach based on volatile organic compounds (VOCs) in exhaled breath. Main objective was the discovery of markers for prediction of blood glucose levels (BGLs) in diabetic patients. Exhaled breath was measured repeatedly in 60 diabetic patients (30 type 1, 30 type 2) in fasting state and after a standardized meal. Proton transfer reaction time of flight mass spectrometry was used to sample breath every 15 min for a total of 6 h. BGLs were tested in parallel via BGM test strips. VOC signals were plotted against glucose trends for each subject to identify correlations. Exhaled indole (a bacterial metabolite of tryptophan) showed significant mean correlation to BGL (with negative trend) and significant individual correlation in 36 patients. The type of diabetes did not affect this result. Additional experiments of one healthy male subject by ingestion of lactulose and13C-labeled glucose (n= 3) revealed that exhaled indole does not directly originate from food digestion by intestinal microbiota. As indole has been linked to human glucose metabolism, it might be a tentative marker in breath for non-invasive BGM. Clinical studies with greater diversity are required for confirmation of such results and further investigation of metabolic pathways. |
Author | Schulat, Jochen Fink, Herbert Maihöfer, Tim Bender, Jeffrey |
Author_xml | – sequence: 1 givenname: Herbert orcidid: 0000-0002-1123-7770 surname: Fink fullname: Fink, Herbert organization: Roche Diabetes Care GmbH, Chemical and Instrumental Analytics , Sandhofer Str 116 Mannheim, 68305 Germany – sequence: 2 givenname: Tim surname: Maihöfer fullname: Maihöfer, Tim organization: Roche Diabetes Care GmbH, Chemical and Instrumental Analytics , Sandhofer Str 116 Mannheim, 68305 Germany – sequence: 3 givenname: Jeffrey surname: Bender fullname: Bender, Jeffrey organization: Roche Diabetes Care Incorporated, Chemical & Instrumental Analytics , 9115 Hague Rd, PO Box 50547, Indianapolis, IN, United States of America – sequence: 4 givenname: Jochen surname: Schulat fullname: Schulat, Jochen organization: Roche Diabetes Care GmbH, Chemical Disposable and Detection , Sandhofer Str 116 Mannheim, 68305 Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34942609$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kctrFTEchYNU7EP3riTgQheOTSavmaUUH4WCG12HPH7T5jo3uU0yVf97M9x6hSJdJYTvC4dzTtFRTBEQeknJe0qG4Zwq0XeKSnZuHJeUPEEnh6ejw12IY3RayoYQyckwPkPHjI-8l2Q8QbeX0acZsCnY4Ag_cYVYTQ13gLcm_4CMQ8Tw68bM4LHNYOoNnlLGLUgX4p0pK2nnlDy-nheXSvNSDDXlEK9xmrAPxkINDpfFbsDV8hw9ncxc4MX9eYa-f_r47eJLd_X18-XFh6vOsVHWTjJGLJmI95z4wcmBM8c9EcIKJZ1k1gNTlHBCKaNmmmAUbgIlRiuFAqHYGXq7_3eX0-0CpeptKA7m2URIS9G9pLzv5UjHhr5-gG7SkmNLp3vVckg1cNqoV_fUYrfg9S6HVtFv_bfMBpA94HIqJcN0QCjR6156HUSv4-j9Xk2RDxQX1vpTrNmE-THx3V4Mafcv7SP4m__gG5s1lbrXpOUnVO_8xP4AVhuzbA |
CODEN | JBROBW |
CitedBy_id | crossref_primary_10_1021_acssensors_4c01699 crossref_primary_10_1109_JSEN_2024_3517472 crossref_primary_10_1021_envhealth_4c00248 crossref_primary_10_1088_1752_7163_acce34 crossref_primary_10_1021_acs_estlett_2c00952 |
ContentType | Journal Article |
Copyright | 2022 IOP Publishing Ltd 2022 IOP Publishing Ltd. |
Copyright_xml | – notice: 2022 IOP Publishing Ltd – notice: 2022 IOP Publishing Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1088/1752-7163/ac4610 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1752-7163 |
ExternalDocumentID | 34942609 10_1088_1752_7163_ac4610 jbrac4610 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Roche Diabetes Care funderid: http://dx.doi.org/10.13039/501100017012 |
GroupedDBID | --- 1JI 4.4 53G 5B3 5GY 5VS 7.M AAGCD AAJIO AATNI ABJNI ABLJU ABVAM ACAFW ACGFS ACHIP AEFHF AENEX AFYNE AKPSB ALMA_UNASSIGNED_HOLDINGS AOAED ASPBG ATQHT AVWKF AZFZN CEBXE CJUJL CRLBU CS3 EBS EDWGO EQZZN F5P IJHAN IOP IZVLO KOT LAP M45 MV1 N5L N9A PJBAE RIN RNS ROL RPA SY9 W28 AAYXX ADEQX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 AEINN |
ID | FETCH-LOGICAL-c396t-6330b0f0dd40d8c6843c4d055b576c63bde3710401131affe95cfe759b657e573 |
IEDL.DBID | IOP |
ISSN | 1752-7155 1752-7163 |
IngestDate | Wed Jul 30 11:31:28 EDT 2025 Mon Jun 30 05:09:07 EDT 2025 Thu Jan 02 22:55:14 EST 2025 Tue Jul 01 04:27:01 EDT 2025 Thu Apr 24 23:06:03 EDT 2025 Wed Aug 21 03:34:43 EDT 2024 Tue Jan 11 22:50:40 EST 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | breath indole non-invasive proton transfer time of flight mass spectrometry diabetes glucose monitoring short chain fatty acid |
Language | English |
License | This article is available under the terms of the IOP-Standard License. https://iopscience.iop.org/page/copyright https://iopscience.iop.org/info/page/text-and-data-mining 2022 IOP Publishing Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c396t-6330b0f0dd40d8c6843c4d055b576c63bde3710401131affe95cfe759b657e573 |
Notes | JBR-101419.R1 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-1123-7770 |
PMID | 34942609 |
PQID | 2733067841 |
PQPubID | 6326151 |
PageCount | 19 |
ParticipantIDs | crossref_primary_10_1088_1752_7163_ac4610 iop_journals_10_1088_1752_7163_ac4610 proquest_journals_2733067841 proquest_miscellaneous_2614226919 crossref_citationtrail_10_1088_1752_7163_ac4610 pubmed_primary_34942609 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-04-01 |
PublicationDateYYYYMMDD | 2022-04-01 |
PublicationDate_xml | – month: 04 year: 2022 text: 2022-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Bristol |
PublicationTitle | Journal of breath research |
PublicationTitleAbbrev | JBR |
PublicationTitleAlternate | J. Breath Res |
PublicationYear | 2022 |
Publisher | IOP Publishing |
Publisher_xml | – name: IOP Publishing |
SSID | ssj0064089 |
Score | 2.333553 |
Snippet | Blood glucose monitoring (BGM) is the most important part of diabetes management. In classical BGM, glucose measurement by test strips involves invasive finger... |
SourceID | proquest pubmed crossref iop |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 026001 |
SubjectTerms | Blood Glucose Blood Glucose Self-Monitoring breath Breath Tests - methods Diabetes Diabetes Mellitus Exhalation Glucose monitoring Humans indole Indoles Male non-invasive proton transfer time of flight mass spectrometry short chain fatty acid VOCs Volatile organic compounds Volatile Organic Compounds - analysis |
Title | Indole as a new tentative marker in exhaled breath for non-invasive blood glucose monitoring of diabetic subjects |
URI | https://iopscience.iop.org/article/10.1088/1752-7163/ac4610 https://www.ncbi.nlm.nih.gov/pubmed/34942609 https://www.proquest.com/docview/2733067841 https://www.proquest.com/docview/2614226919 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB615cKFV3mkFDRIgMQhu3nYjiNOFaIqSDwOVOoByfIr6hY2u93NVsCvZ-xkFxVBhbhFyiRxxo_5ZvzNGOBp7iV3RUjdYhVPmRc21czY1DhJ9tDUTWVCQP_de3F0zN6e8JMteLnJhZnNh6V_RJd9oeBehQMhTo7J4BEoJBwx1jZUC9-Ga6Ukwxmy9z58XC_DgmXx_LtBmvNhj_JPb7hkk7bpu3-Hm9HsHN6Ez-sG92yTL6NVZ0b2x2-1HP_zj27BjQGO4kEvehu2fHsHdg9acsWn3_E5RoJojLzvwvmbNpR_Qr1EjYTGsevzli48TgPJZ4GTFv23UzI5Dk0Ao6dIkBjbWZtO2gsdiPIYifI4EOVxGleUEFrEWYN9HHhicbkyITy0vAvHh68_vTpKhxMbUlvWoktFWWYmazLnWOakFZKVlrmMc0NujRWlcb4kSEM-XV7muml8zW3jK14bwSvPq_Ie7FCj_ANAK2vmJJcEUSomfKELrxtN6MvaKsssS2C87jNlh3Lm4VSNrypuq0upglZV0KrqtZrAi80T876UxxWyz6iz1DCfl1fI4SW5M7NQuVCFCqXaslzNXZPA_nos_ZIj0Bh8NcnyBJ5sbtPMDts1uvWzFcmImOZc53UC9_sxuGl3KCpEX6j3_rGdD-F6EfI2IuVoH3a6xco_IjTVmcdx1vwEemAURg |
linkProvider | IOP Publishing |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB61RUJceJVHoMAgUSQOTvzYXa8PHCpK1FAoPVCpt2V3vVZDGyckTqH8Kf4KP4lZ2wkqgopLD9wieeyMd8cz3-zONwvwLHKS57GnbrGUB8wJG2hmbGBySfHQZEVq_IL-uz2xc8DeHPLDFfi-5MKMJ63r79LPplFwM4RtQZzsUcAjUEg4oqet7xbem-RFW1W5686-UM42eznYpgnejOP-6w-vdoL2WIHAJpmoAkEpvAmLMM9ZmEsrJEssy0PODWFvKxKTu4TiLiUeURLponAZt4VLeWYETx1PE3ruKlzhCcVqzxh8v79w_YKF9Zl7rYact_uif9L6XBxcpXf9O8StQ13_BvxYDFJT4XLcnVema7_91j_yPxrFm3C9hd241ah3C1ZceRvWt0pdjUdn-BzrQth6h2EdPg9K3-YK9Qw1UtaBVcPPOnU48sVMUxyW6L4eUWjN0XjQfYQE_bEcl8GwPNWeEIA1IQBbQgCOas_pl1BxXGCz3j20OJsbvww2uwMHl_Lyd2GNlHL3Aa3MWC65JCiWMuFiHTtdaEKZ1qZhaFkHegs7UbZt2-5PDzlRdfmAlMrPpPIzqZqZ7MCL5R2TpmXJBbKbZCCq9VuzC-TwnNwnM1WRULHyLenCSJHxdGBjYb-_5Agc-5xUsqgDT5eXyYP5bSlduvGcZERN586irAP3Grtf6u2bJ9E_ZA_-Uc8ncHV_u6_eDvZ2H8K12FNV6iqrDVirpnP3iABkZR7XHy3Cx8u275_WuHJx |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Indole+as+a+new+tentative+marker+in+exhaled+breath+for+non-invasive+blood+glucose+monitoring+of+diabetic+subjects&rft.jtitle=Journal+of+breath+research&rft.au=Fink%2C+Herbert&rft.au=Maih%C3%B6fer%2C+Tim&rft.au=Bender%2C+Jeffrey&rft.au=Schulat%2C+Jochen&rft.date=2022-04-01&rft.eissn=1752-7163&rft.volume=16&rft.issue=2&rft_id=info:doi/10.1088%2F1752-7163%2Fac4610&rft_id=info%3Apmid%2F34942609&rft.externalDocID=34942609 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1752-7155&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1752-7155&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1752-7155&client=summon |